Cardiometabolic Beat Podcast

Future leaders in cardiometabolic health Revathy Sampath-Kumar, MD and L. Nedda Dastmalchi, DO discuss how being part of this program and attending a CMHC event has helped them in their career, in a conversation with CMHC's Senior Planning Committee Member Pam Taub, MD.

Watch Drs. Tsimikas, Aleppo, and Shah discuss the benefits of digital interventions, including CGMs while managing people with diabetes.

(Recorded October 18, 2023)

Watch Dr. Seth Martin, MD, MHS, discussing the significance of the role of technology and digital health in cardiometabolic risk reduction.

(Recorded October 18, 2023)

Watch Drs. Ryan and Still discuss the pros and cons of both pharmacotherapy and bariatric surgery while managing people with obesity.

(Recorded October 19, 2023)

Watch as CMHC Faculty Pam Taub MD and Ajay Singh MD recapped cardio-renal session at CMHC Annual 2023, where they discussed how cardiologists and nephrologists can work together to tackle cardio-renal diseases, including the latest cardio-renal therapies.

(Recorded October 21, 2023)

Watch as CMHC Faculty Christie Ballantyne, MD, Robert Eckel, MD, Erin Michos, MD, Patrick Moriarty, MD, and Paul Ridker, MD, discuss practical pearls about the spectrum of residual ASCVD risk, including:

Recorded October 20, 2023

Watch CMHC Faculty Francoise Marvel, MD and Daichi Shimbo, MD discuss challenges and practical pearls for the use of digital health technologies, focusing on remote blood pressure monitoring and telehealth visits (recorded October 18, 2023).

Watch as CMHC faculty Juan Frías, MD and Shivani Agarwal, MD discuss important pearls in the management of type 2 diabetes, including screening for social determinants of health (SDOH), the impact of SDOH on treatment, culturally-sensitive care, as well as the importance of early glycemic control, screening, and GDMT optimization (recorded October 20, 2023).

Watch as CMHC faculty Christie Ballantyne, MD, Robert Eckel, MD, Keith Ferdinand, MD, and Anne Peters, MD recap some of the main developments in 2023 across the cardio-renal-metabolic health as discussed at the 18th CMHC Annual meeting, including in obesity, diabetes, dyslipidemia/ASCVD risk, hypertension, and more (recorded October 19, 2023).

Watch CMHC co-chairs Christie Ballantyne, MD and Robert Eckel, MD discuss the connections between cardio-renal-metabolic health, and the value of attending the CMCH Annual meeting (recorded October 2023).

Vanita Aroda, MD, Associate Professor of Medicine at Harvard Medical School, and Katherine Tuttle, MD, Professor of Medicine at the University of Washington, discuss current disparities in the treatment of women with type 2 diabetes and cardiorenal risk despite the evidence and breadth of available agents. They discuss that women are less likely to receive guideline-directed medical therapy, including both older and newer agents, and less likely to enroll in clinical trials, as well as the need to recognize and address these disparities.

Recorded during 2023 CMHC's Women's Health Masterclass, August 19, 2023.

2023 CMHC's Women's Health Masterclass Co-Chairs Erin Michos, MD and Pam Taub, MD recap the obesity & lifestyle sessions, and in conversation with Fatima Rodriguez, MD, discuss practical pearls for the management of obesity in women across the lifespan, including the synergy between lifestyle interventions and pharmacotherapy, and how to facilitate the dialogue in patients with overweight and obesity to improve overall cardiovascular risk.

Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.

Rachel Bond, MD, System Director of the Women's Heart Health Program at Dignity Health in AZ, has a conversation with Chrisandra Shufelt, MD, Professor of Medicine at Mayo Clinic in FL, about unique cardiometabolic risk factors in women. They discuss the impact of adverse pregnancy outcomes across the lifespan and changes associated with the menopause transition on overall cardiometabolic risk assessment, as well as important clinical pearls in this setting.

Recorded during 2023 CMHC's Women's Health Masterclass, August 18, 2023.

Brittany Weber, MD, PhD, Director of the Cardio-Rheumatology Clinical at Brigham and Women's Hospital, discusses the role of systemic inflammation in promoting cardiovascular risk, the link between systemic inflammatory conditions (such as rheumatoid arthritis, psoriatic arthritis, and others) and cardiovascular adverse events, and how cardiologists and rheumatologists can work together to manage patients with these comorbid conditions.

Recorded at 2023 CMHC Spring, May 19, 2023

During this interview, Jennifer Green, MD, Professor of Medicine at Duke, discusses the multimorbidity in patients with type 2 diabetes, the role of inflammation as a driver of multimorbidity in this setting, as well as practical pearls for the utilization of newer cardio-renal protective agents in these patients.

Recorded at 2023 CMHC Spring, May 20, 2023

CMHC Co-Chair George Bakris, MD, Professor of Medicine at University of Chicago, reviews the association between inflammation and hypertension, as well as provides important clinical pearls for the management of hypertension and how to best utilize the existing treatment options.

Recorded May 19, 2023.

CMHC Faculty, Ileana Piña, MD, Professor of Medicine Thomas Jefferson University, discusses the connections between inflammation and heart failure, trials looking at targeting inflammation in this setting, and the importance of shared decision-making in treating patients with heart failure.

Recorded on May 19, 2023.

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum

Episode 3: A Patient with Sleep Apnea & Comorbidities

with Virend Somers, MD, PhD, Deborah Clegg, PhD, RD, and Gregg Pressman, MD, FACC, FASE

In this 3-part podcast series, Virend Somers, MD, PhD, Professor at the Department of Cardiovascular Medicine at Mayo Clinic moderates discussions with Deborah Clegg, PhD, RD, Professor of Internal Medicine at Texas Tech University and Gregg Pressman, MD, FACC, FASE, Professor of Medicine at Thomas Jefferson University on salt, sleep, and how these relate to increased cardiovascular risk.  They discuss the risk of increased sodium intake in patients with CVD or at CVD risk, including in patients with sleep disorders, as well as practical strategies to minimize the impact of elevated sodium.

Recorded May 4, 2023.

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum

Episode 2: Sodium as a Driver of Cardiovascular and Cardiometabolic Risk

with Virend Somers, MD, PhD, Deborah Clegg, PhD, RD, and Gregg Pressman, MD, FACC, FASE

In this 3-part podcast series, Virend Somers, MD, PhD, Professor at the Department of Cardiovascular Medicine at Mayo Clinic moderates discussions with Deborah Clegg, PhD, RD, Professor of Internal Medicine at Texas Tech University and Gregg Pressman, MD, FACC, FASE, Professor of Medicine at Thomas Jefferson University on salt, sleep, and how these relate to increased cardiovascular risk.  They discuss the risk of increased sodium intake in patients with CVD or at CVD risk, including in patients with sleep disorders, as well as practical strategies to minimize the impact of elevated sodium.

Recorded May 4, 2023.

Reducing the Impact of High Sodium Intake to Optimize CVD Risk Across the Spectrum 

Episode 1: Sodium Loading in Narcolepsy

with Virend Somers, MD, PhD, Deborah Clegg, PhD, RD, and Gregg Pressman, MD, FACC, FASE

In this 3-part podcast series, Virend Somers, MD, PhD, Professor at the Department of Cardiovascular Medicine at Mayo Clinic moderates discussions with Deborah Clegg, PhD, RD, Professor of Internal Medicine at Texas Tech University and Gregg Pressman, MD, FACC, FASE, Professor of Medicine at Thomas Jefferson University on salt, sleep, and how these relate to increased cardiovascular risk.  They discuss the risk of increased sodium intake in patients with CVD or at CVD risk, including in patients with sleep disorders, as well as practical strategies to minimize the impact of elevated sodium.

Recorded May 4, 2023.

CMHC co-chair Robert Eckel, MD moderates a conversation with Chip Lavie, MD, Virend Somers, MD, and Pam Taub, MD about the interesting intersection between inflammation and lifestyle. The panel shares practical pearls about the role of diet, physical activity, stress and disrupted sleep on inflammation and the importance of addressing these comprehensive lifestyle components to improve cardiometabolic health.

Recorded at 2023 CMHC Spring, May 19, 2023.

CMHC co-chair Christie Ballantyne, MD and Erin Michos, MD discuss the biology behind inflammation and obesity, obesity as an underappreciated but major CVD risk factor, and the ever-changing landscape of obesity treatment, with several approaches that have been recently approved or are in clinical development. They also share important practical pearls about the role of newer anti-obesity medications in conjunction with lifestyle for the long-term management of obesity.

Recorded at 2023 CMHC Spring, May 19, 2023

In honor of both Black History Month this February 2023 and the upcoming Women’s History Month in March 2023, CMHC was excited to host a unique webinar that highlighted some of the challenges and advances in managing cardiometabolic health in these populations.

Dr. Ferdinand led a discussion with Drs. James Gavin and Rachel Bond about the importance of diversity and inclusion in cardiometabolic health, with a focus on social determinants of health in the management of diabetes, managing women’s cardiovascular risk across the lifespan, as well as strategies for multidisciplinary collaboration. The webinar opened forum and will aim to offer real discussion on practical strategies to advance care and optimize outcomes.

In episode three, Dr. Fatima Cody Stanford and Dr. Scott Butsch tackle the importance of addressing obesity in patients with type 2 diabetes, and cover both new and established interventions to manage both conditions.

In the second episode of this podcast series, Dr. Fatima Cody Stanford and Dr. Scott Butsch discuss practical ways to improve patient outcomes while overcoming barriers within the primary care setting.

In the first of three episodes, Dr. Fatima Cody Stanford interviews Dr. Scott Butsch regarding effective strategies for discussing the financial burden, physical limitations, and significant health risks with patients who have both obesity and type 2 diabetes.

Today we have Dr. Anne Peters on the podcast telling us all about Continuous Glucose Monitoring for Patients.

Don't forget to rate, subscribe/follow, and leave us a 5-star review!

Dr. Holly Wyatt's love for research began when she was just a child. She credits her father, an electrical engineer, with sparking her curiosity for the sciences and putting her on the path to becoming the clinical scientist she is today. Her personal challenges with “stopping the yo-yo” of dieting drove her to seek answers about metabolism and how the body and mind work together when it comes to losing weight and keeping it off forever. You don't want to miss her tips and tricks for treating patients with obesity in this podcast episode.

If you haven't already, don't forget to rate, subscribe/follow, and leave us a 5-star review!

Recent data and the FDA approval of tirzepatide have generated a lot excitement in the medical community about the role of this agent in the treatment of type 2 diabetes and obesity. In this podcast, CMHC Co-Chair Dr. Anne Peters, Professor of Medicine at the University of Southern California in LA, discusses the clinical implications of this agent and its potential role now and going forward.

Don't forget to rate, subscribe/follow, and leave us a 5-star review!

Tune in to listen to Joe E. Pizzorno, ND, one of the world's leading experts on science-based natural and integrative medicine, talk about the impact of environmental toxins in the development and exacerbation of cardiometabolic diseases, as well as what clinicians and patients can do to lower their burden on health and outcomes. Also, please don't forget to rate, subscribe/follow, and leave us a 5-star review!

The American Diabetes Association (ADA) Standards of Care is an important guideline that sets the tone about diabetes treatment in the US. Tune to listen to CMHC Co-Chair Dr. Anne Peters, Professor of Medicine at the University of Southern California in LA and co-author of the ADA Standards of Care, discuss important updates in the 2022 guidance.

Don't forget to rate, subscribe/follow, and leave us a 5 star review!

Dr. Filomena Trindade, a physician, teacher, author, and internationally recognized speaker who focuses on functional medicine and a holistic preventative approach to care discusses the potential reversal of Type 2 Diabetes. You don't want to miss what she has to say! Also, don't forget to rate, subscribe or follow, and leave a 5 star review!

Tune in to listen to Kenneth Cusi, MD talk about the increasing burden of NAFLD and NASH, important considerations for screening and diagnosis that clinicians in the community should be aware of, as well as perspectives about current and emerging treatments.

Listen in as Dr. George Bakris, the Director of the Comprehensive Hypertension Center and kidney disease specialist, discusses the latest cardiometabolic concepts and new ways to help create helpful healing plans for patients.

Listen in as Dr. Mark Houston, the Director of the Hypertension Institute - tripled boarded in hypertension as an American Society of Hypertension specialist, a Fellow of the American Society of Hypertension, Internal Medicine, and Anti-aging medicine discusses the emerging strategies in cardiometabolic medicine.

Despite therapeutic advances, the cardiometabolic disease burden remains disproportionally high in patients from racial and ethnic populations. The reasons for these disparities are complex and underlined by social determinants of health and limited access to appropriate healthcare, among other factors. During this webinar, Dr. Keith C. Ferdinand, MD, hosted a panel with key opinion leaders to discuss the current state of these disparities as well as strategies to better help close these gaps going forward.

Recorded February 22, 2022

Listen in as Fatima Stanford, MD, Associate Professor of Medicine and Pediatrics, as well as Equity Director at Massachusetts General Hospital Endocrine Division, shares some practical pearls about addressing disparities in the management of obesity.

Tune in to hear Javed Butler, MD, renowned heart failure (HF) specialist and the principal investigator of several major HF trials, discuss the evolving paradigms of HF care, including the role of SGLT-2 inhibitors as part of foundational therapy, as well as other newer and emerging treatment options and their role in the treatment landscape.

Listen in to our conversation with renowned nephrologist and long-term CMHC faculty Mathew R. Weir, MD, who is Professor of Medicine and Division Head of Nephrology at University of Maryland School of Medicine. In this podcast, Dr. Weir covers the exciting new developments in the management of CKD, including SGLT-2 inhibitors and beyond, as well as practical pearls for better adopting these advances to patient care.

Listen in to our conversation with Linda Shiue, MD, an internist and professionally trained chef in the department of Adult and Family Medicine and the Director of Culinary Medicine at Kaiser Permanente San Francisco, and the author of the cookbook "Spicebox Kitchen: Eat Well and Be Healthy with globally inspired, vegetable-forward recipes".  In the podcast, she shares her unique insights on food as medicine, as well as some practical advice on how to better address nutrition in clinical practice. 

RECORDED January 11, 2022

VTE: A Discussion on Screening, Prevention, and Transition of Care

Listen in as Dr. Geoffrey Barnes, Assistant Professor of Medicine, as well as a cardiologist and vascular medicine specialist at the University of Michigan Health system, shares his clinical perspectives on the prevention and management of venous thromboembolism (VTE).

Recorded September 16, 2021.

COVID-19 and New-Onset Diabetes

Listen in as Dr. Irl Hirsch, Professor of Medicine and Diabetes Treatment and Teaching Chair at the University of Washington Medical Center in Seattle, WA., presents on an intriguing topic, that of new-onset diabetes due to COVID-19.

Recorded September 21, 2021.

Listen in as Dr. Vanita Aroda, Director of Diabetes Clinical Research at the Brigham and Women's Hospital in Boston and faculty at Harvard Medical School, covers the ever-changing landscape and paradigm shifts in the management of patients with type 2 diabetes.

Recorded September 14, 2021

Listen in as Dr. Keith Ferdinand, Professor of Medicine and Gerald S. Berenson Endowed Chair in Preventive Cardiology at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana shares his insight on ethnic & racial disparities in cardiometabolic health. Dr. Ferdinand has dedicated his career to improving these disparities, and was more recently named as CMHC's Educational Planning Advisor for Ethnic & Racial Disparities in Cardiometabolic Health.

Recorded Aug 10, 2021

Listen in as Dr. Adam DeVore, cardiologist and Associate Professor of Medicine at Duke University School of Medicine in Durham, North Carolina share results from the CONNECT-HF trial.

Recorded Date July 12, 2021

Dr. Hallberg is a nationally and internationally recognized expert in the field of carbohydrate restriction for type 2 diabetes, and part of the largest and longest trial to date in this field. In this interview Dr. Hallberg discusses the evidence behind ketogenic/low carb diets in reducing cardiometabolic risk and much more.

Listen to CMHC's Senior Planning Committee Member and Spring 2021 Keynote, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss ethnic and racial disparaties among caring for patients with cardiometabolic risk and COVID-19.

Dr. Harold Bays, Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center as well as Your Body Goal in Louisville, KY., and Chief Science Officer of Obesity Medicine Association shares his insight on obesity pharmacotherapy, cardiometabolic consequences of obesity as well as how the COVID-19 pandemic impacts obesity management.

Since the month of May is celebrated as Asian Pacific Heritage Month, in this podcast, we had an opportunity to talk with Dr. Leslie Cho, Professor of Medicine and Head of Preventive Cardiology and Rehabilitation at the Cleveland Clinic, Ohio, about the prevalence and management of statin intolerance particularly in individuals of East Asian descent.

In this podcast, CMHC Chair Christie Ballantyne, MD, Professor of Medicine at Baylor College of Medicine, discusses the role of troponins and statins in COVID-19, and how has the pandemic impacted his practice.

In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.

Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.

In this podcast, CMHC chair Dr. Anne Peters, Professor of Medicine and Director of Clinical Diabetes Programs at the University of Southern California in LA, discusses the impact of COVID-19 in patients with diabetes.